Results 201 to 210 of about 217,974 (267)
Copper‐Doped Prussian Blue Nanozymes With Hyaluronic Acid‐Mediated Targeting Alleviate Oxidative Stress and Regulate Cholesterol Handling for Atherosclerosis Therapy
Advanced Science, EarlyView.CuPB@HA is a CD44‐associated, plaque‐targeted nanozyme that alleviates oxidative stress, inflammation, and lipid accumulation in macrophages. By reducing CD36‐dependent lipid uptake and promoting ABCA1/ABCG1‐mediated cholesterol handling, it improves macrophage function, preferentially accumulates in atherosclerotic lesions, reduces plaque burden, and ...Jianliang Ou, Ruihua Ji, Qinglu Zang, Mingkang Wang, Lingling Zhou, Yingliang Wei, Di Yang, Yue Wu, Hongxu Zhu, Jianrong Wu, Xiaojun Cai, Wenxian Du, Junjie Cheng, An Zeng, Yuehua Li +14 morewiley +1 more sourceCorrection: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
Blood Cancer JournalTara Sebastian, Sridevi Rajeeve, Tasmin Farzana, Ross Firestone, Eric Jurgens, Kevin Miller, Bruno Almeida Costa, Alexander Lesokhin, Carlyn Rose Tan, Gunjan Shah, Neha Korde, Heather Landau, Michael Scordo, Hani Hassoun, Kylee Maclachlan, Urvi Shah, Malin Hultcrantz, Andriy Derkach, Derkach Nemirovsky, Sergio Giralt, Saad Usmani, Sham Mailankody, Hamza Hashmi +22 moredoaj +1 more sourceMagneto‐NIR‐II‐Programmed Cascade Nanozymes Unlocking Blood–Brain Barrier Translocation and Autophagic Resistance in Glioblastoma
Advanced Science, EarlyView.Magneto‐NIR‐II‐programmed NFSH nanozymes integrate magnetic blood–brain barrier (BBB) translocation, CD44 targeting, multimodal imaging, and cascade catalytic therapy for glioblastoma. Alternating magnetic fields and NIR‐II irradiation amplify ferroptosis, release H2S, suppress autophagic and mitophagic repair, and reshape the immune microenvironment ...Ruocan Liu, Yundi Wu, Shuai Zhang, Hongjuan Zhao, Jiping Zheng, Shiyang Shao, Jianqiang Chen, Xilong Wu +7 morewiley +1 more sourceImpact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
Blood Cancer JournalTara Sebastian, Sridevi Rajeeve, Tasmin Farzana, Ross Firestone, Eric Jurgens, Kevin Miller, Bruno Almeida Costa, Alexander Lesokhin, Carlyn Rose Tan, Gunjan Shah, Neha Korde, Heather Landau, Michael Scordo, Hani Hassoun, Kylee Maclachlan, Urvi Shah, Malin Hultcrantz, Andriy Derkach, David Nemirovsky, Sergio Giralt, Saad Usmani, Sham Mailankody, Hamza Hashmi +22 moredoaj +1 more sourceA C‐Nucleoside Analogue of Cordycepin With High Metabolic Stability and Potent Anti‐Psoriatic Activity via Microneedle Delivery
Advanced Science, EarlyView.This work identified CPD3a as a potent, stable C‐nucleoside cordycepin derivative. When formulated into microneedle array for topical treatment, it ameliorated psoriasis by rebalancing immunity and enhancing antioxidant defenses. ABSTRACT
Psoriasis is a chronic inflammatory disorder characterized by immune dysregulation and epidermal hyperplasia ...Wenfang Pan, Xinyue Shao, Yuanchen Zhong, Xujie Sun, Lixuan Yin, Zongyan He, Tianqun Lang, Yuanchao Xie +7 morewiley +1 more sourceExploratory Association of 5' and 3' UTRs Variants in <i>TYMS</i> and <i>CCND1</i> with Severe Hematologic Toxicity in Pediatric Acute Lymphoblastic Leukemia. [PDF]
Int J Mol SciRojo-Serrato D, Flores-Murrieta FJ, Rosas-Vargas H, Jiménez-Hernández E, Núñez-Enríquez JC, González-Torres C, Gaytan-Cervantes J, Escalante-Bautista D, Pérez-Saldivar ML, Flores-Lujano J, Jasso-Mata AM, Marquez-Águilar AE, Sotelo Hernández JÁ, Sepúlveda-Robles OA, Romero-Tlalolini MLÁ, Alaez-Verson C, Martín-Trejo JA, Jiménez-Morales S, Cruz-Jaramillo JL, Anda NAO, Castillo-Mendéz MA, Torres-Nava JR, Flores-Villegas LV, Merino-Pasaye LE, Miranda-Madrazo MR, Gutiérrez-Rivera ML, Solís-Labastida KA, Herández-Echaurregui GA, Melendez-Zajgla J, Rangel-López A, Arellano-Galindo J, Mata-Rocha M, Mejía-Aranguré JM. +32 moreeuropepmc +1 more source
